A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland. Dr. Oliver Gautschi, a…
Source:Some lung cancer patients can benefit from melanoma drugs
Monday, April 20, 2015
Some lung cancer patients can benefit from melanoma drugs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment